| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/03/2008 | CN101258149A Thiazole derivatives and use thereof |
| 09/03/2008 | CN101257919A Antigen-and-drug vehicle which enables the changeover from the selective production of lgA antibody to the production of both of lgA and lgG antibodies, and transnasal/transmucosal vaccine using the v |
| 09/03/2008 | CN101257909A Core 2 glcnac-t inhibitors |
| 09/03/2008 | CN101257904A Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 09/03/2008 | CN101255434A Vaccines |
| 09/03/2008 | CN101255425A OX2 receptor homolog |
| 09/03/2008 | CN101255199A Method for extracting Siberian solomonseal rhizome polysaccharide from siberian solomonseal rhizome |
| 09/03/2008 | CN101255192A Soluble CTLA4 mutant molecules and uses thereof |
| 09/03/2008 | CN101255189A Animal vaccine immunopotentiator and production method thereof |
| 09/03/2008 | CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 09/03/2008 | CN101254298A Hoarfrost agent for antioxidation and improving human body immunity and method of preparing the same |
| 09/03/2008 | CN101254281A Sub-health herbal medicine pills and method of preparing the same |
| 09/03/2008 | CN101254240A Gene therapy for radically treating hepatitis B |
| 09/03/2008 | CN101254233A Gene therapy for radical curing SARS respiratory disease |
| 09/03/2008 | CN101254231A Preparation for curing perennial allergic rhinitis external-use traditional Chinese medicine preparation |
| 09/03/2008 | CN101254213A Conditioned medium and its uses |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415735C Amino alcohol derivatives |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415723C Benzimidazole derivative |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415716C 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative |
| 09/03/2008 | CN100415292C New class of bioactive glycoprotein |
| 09/03/2008 | CN100415252C Chinese medicinal composition for strengthening body and enriching blood and its preparation method |
| 09/03/2008 | CN100415233C Oral formulations |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/03/2008 | CN100415223C Controlled releasing oral medicine composition |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420053 2-imino-1,3-thiazine derivatives |
| 09/02/2008 | US7420047 Nucleotide sequence encoding antigenic peptide; induces immune response which does not cause anaphylaxis when administered; safety |
| 09/02/2008 | US7420003 Compounds and a novel process for their preparation |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419976 Diazepanes derivatives useful as IFA inhibitors |
| 09/02/2008 | US7419966 Viricides; human t-cell leukemia, lymphoma virus |
| 09/02/2008 | US7419958 Antagonists that bind CD1d and inhibit activation of CD1d-restricted natural killer (NK) T cells, agents that block CD1d-specific receptors and CD1d decoys and a carrier or diluent; contact dermatitis for example |
| 09/02/2008 | US7419956 Isolated physiologically active peptide and use thereof |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | US7419669 Peptide epitopes common to antigens of the same multigene family |
| 09/02/2008 | US7419667 Drug for cancer therapy |
| 09/02/2008 | CA2426956C Pharmaceutical compositions comprising ascomycin derivatives |
| 09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 09/02/2008 | CA2325818C Topical immunostimulation to induce langerhans cell migration |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008103473A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | WO2008103432A1 Engineered anti-il-23p19 antibodies |
| 08/28/2008 | WO2008103397A1 Suppression of allergic inflammation by ascaris aba-1 antigen |
| 08/28/2008 | WO2008103392A2 Modulation of nkt cell activity with antigen-loaded cdid molecules |
| 08/28/2008 | WO2008102937A1 Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression |
| 08/28/2008 | WO2008102888A1 Novel pseudoglycolipid and use thereof |
| 08/28/2008 | WO2008101953A1 Compounds of formula (i) as serine protease inhibitors |
| 08/28/2008 | WO2008101450A1 Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans |
| 08/28/2008 | WO2008101349A1 Recombinant viral vectors for prevention and protection against alphavirus infection |
| 08/28/2008 | WO2008083239A3 Compositions and methods for stimulating an immune response |
| 08/28/2008 | WO2008080218A9 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 08/28/2008 | WO2008056202A3 Desloratadine crystalline forms mixtures having a low level of residual solvents |
| 08/28/2008 | WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 08/28/2008 | WO2007102769A3 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 08/28/2008 | WO2007054989A9 Method for the preparation of anallergic probiotic bacterial cultures and related use |
| 08/28/2008 | US20080207902 Phosphodiesterase inhibitors; side effect reduction |
| 08/28/2008 | US20080207764 Novel Benzamidine Derivatives Having Anti-Inflammatory and Immunosuppressive Activity |
| 08/28/2008 | US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents |
| 08/28/2008 | US20080207725 Skin disorders; antiinflamamtory agenst; antiallergens |
| 08/28/2008 | US20080207699 Pyrazole Derivatives |
| 08/28/2008 | US20080207689 Formamide Derivatives For The Treatment of Diseases |
| 08/28/2008 | US20080207683 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207641 Immunosuppressants; antiallergens |
| 08/28/2008 | US20080207617 Prevent autophosphorylation of tyrosine kinase; therapy for hematopoietic cancer; leukemia; myelodysplastic syndrome |
| 08/28/2008 | US20080207613 Selective Kinase Inhibitors |
| 08/28/2008 | US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders |
| 08/28/2008 | US20080207609 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents |
| 08/28/2008 | US20080207606 Immunology diseases; analgesics; antiarthritic agents; cardiovascular disorders; antiischemic agents; skin disorders;antiulcer agents; bone disorders; antihistamines |
| 08/28/2008 | US20080207593 Antihistamine Combination |
| 08/28/2008 | US20080207580 Method of treating immune pathologies with low dose estrogen |
| 08/28/2008 | US20080207550 Immunomodulatory polynucleotides and methods of using the same |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207496 Mixture of staurosporine and drug for transplant rejection |
| 08/28/2008 | US20080206835 Methods and Compositions Relating to Gene Silencing |
| 08/28/2008 | US20080206375 Composition of Radix Codonopsis and Radix Astragali, a Method for Preparation Thereof and its Application |
| 08/28/2008 | US20080206374 Purification, washing with deionized water, heating and extracting, condensing, depositing with ethanol; immunomodulators, antiischemic agents |
| 08/28/2008 | US20080206322 Advantageous properties when administered orally; consistency of pharmacokinetic behavior achieved; exhibits less fatty food interaction; time release coating reduces variation in mycophenolic acid exposure from one day to the next or from day time to night |
| 08/28/2008 | US20080206319 Mucosal adjuvants elicit strong balanced or adjusted immune response of humoral, cellular components; prophylaxis or treatment of infectious diseases or cancer; non-toxic; employed with a wide variety of active ingredients to be assisted in conventional or novel vaccines |
| 08/28/2008 | US20080206318 Administering complex formed from a soluble tumor-associated antigen and an antibody or antigen binding fragment thereof that binds to a first epitope of the tumor-associated antigen, wherein the tumor-associated antigen is CA 125 for therapy of oncological disease |
| 08/28/2008 | US20080206312 Therapeutic Morpholino-Substituted Compounds |
| 08/28/2008 | US20080206289 identifying a human subject as a candidate for prostate cancer examination by determining whether the human has developed an immune reaction to a prostate cancer antigen; drug screening |
| 08/28/2008 | US20080206284 E. coli heat-labile enterotoxin that binds to GM1 ganglioside receptors; allergic rhinitis |
| 08/28/2008 | US20080206281 Method For Producing Storage Stable Viruses and Immunogenic Compositions Thereof |
| 08/28/2008 | US20080206280 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases |
| 08/28/2008 | US20080206271 Contains a binding ligand, a Pseudomonas exotoxin A translocation domain II, an antigenic moiety, and a carboxyl terminal moiety which binds to the endoplasmic reticulum of the target T-cells, B-cells, dendritic cells, monocytes, or macrophages; inoculation |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206262 complexing of multiple antigens or proteins in a controlled, multivariable fashion, to one single primary recombinant monoclonal antibody; activate dendritic cells and other cells; bound to one half of a Coherin/Dockerin pair |